DOAC-Remove™ 250 Ref. No. 5D-82410C
DOAC-Remove™ 250 tablets are intended to be used for removal of Direct Oral Anticoagulant (DOAC) compounds from human citrated plasma samples, including dabigatran, rivaroxaban, apixaban and edoxaban. Also removes argatroban. DOAC-Remove™ has no significant effect on clotting factors. Currently not for sale in US.
Description
Removes DOACs and argatroban from citrated plasmas thereby reducing interference when the plasma is tested in laboratory coagulation assays such as APTT, TT, single factors, lupus AC, and APC-R.
DOAC-Remove™ is a CE marked product made to the exact specifications of 5-Diagnostics
For In Vitro Use Only.
Additional information
| Size | 250 tablets |
|---|
